Literature DB >> 30374857

Molecular characterization of Wnt pathway and function of β-catenin overexpression in medulloblastoma cell lines.

Lenisa Geron1, Karina Bezerra Salomão2, Kleiton Silva Borges3, Augusto Faria Andrade2, Carolina Alves Pereira Corrêa2, Carlos Alberto Scrideli3, Luiz Gonzaga Tone3,2.   

Abstract

Medulloblastoma (MB) is the most common malignant childhood brain tumor. MB is currently classified into four molecular subgroups (Wnt, Shh, Group 3, and Group 4). The wingless (Wnt) pathway is responsible for embryonic development and is deregulated in MB. We analyzed the activation of the Wnt pathway in MB cell lines and its correlation with the Shh pathway, with emphasis on the importance of cellular characterization. Transient β-catenin transfection led to an increase in the β-catenin gene and protein expression in MB cell lines. Wnt pathway activation resulted in a reduced number of colonies in all cell lines studied and a significant increase in the G2/M cell cycle phase only in ONS-76 cells. Regarding the Shh pathway, transfection caused a reduced expression of the PTCH1 and SMO genes only in the UW473 cells. Further studies are needed to understand the mechanism underlying the molecular events associated with the effects of Wnt activation in MB.

Entities:  

Keywords:  Medulloblatoma; Wnt pathway; β-Catenin

Year:  2018        PMID: 30374857      PMCID: PMC6269366          DOI: 10.1007/s10616-018-0260-2

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  43 in total

Review 1.  The Hedgehog and Wnt signalling pathways in cancer.

Authors:  J Taipale; P A Beachy
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 2.  An overview of the Notch signalling pathway.

Authors:  Martin Baron
Journal:  Semin Cell Dev Biol       Date:  2003-04       Impact factor: 7.727

3.  Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation.

Authors:  Jennifer Pogoriler; Kathleen Millen; Manuel Utset; Wei Du
Journal:  Development       Date:  2006-08-30       Impact factor: 6.868

4.  Wnt activation affects proliferation, invasiveness and radiosensitivity in medulloblastoma.

Authors:  Roberta Salaroli; Alice Ronchi; Francesca Romana Buttarelli; Filippo Cortesi; Valeria Marchese; Elena Della Bella; Cristiano Renna; Caterina Baldi; Felice Giangaspero; Giovanna Cenacchi
Journal:  J Neurooncol       Date:  2014-09-28       Impact factor: 4.130

5.  Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.

Authors:  Flora Cimmino; Maria Nunzia Scoppettuolo; Marianeve Carotenuto; Pasqualino De Antonellis; Valeria Di Dato; Gennaro De Vita; Massimo Zollo
Journal:  J Neurooncol       Date:  2011-07-07       Impact factor: 4.130

6.  Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children.

Authors:  Joanna Triscott; Cathy Lee; Colleen Foster; Branavan Manoranjan; Mary Rose Pambid; Rachel Berns; Abbas Fotovati; Chitra Venugopal; Katrina O'Halloran; Aru Narendran; Cynthia Hawkins; Vijay Ramaswamy; Eric Bouffet; Michael D Taylor; Ash Singhal; Juliette Hukin; Rod Rassekh; Stephen Yip; Paul Northcott; Sheila K Singh; Christopher Dunham; Sandra E Dunn
Journal:  Cancer Res       Date:  2013-09-09       Impact factor: 12.701

7.  Intertumoral Heterogeneity within Medulloblastoma Subgroups.

Authors:  Florence M G Cavalli; Marc Remke; Ladislav Rampasek; John Peacock; David J H Shih; Betty Luu; Livia Garzia; Jonathon Torchia; Carolina Nor; A Sorana Morrissy; Sameer Agnihotri; Yuan Yao Thompson; Claudia M Kuzan-Fischer; Hamza Farooq; Keren Isaev; Craig Daniels; Byung-Kyu Cho; Seung-Ki Kim; Kyu-Chang Wang; Ji Yeoun Lee; Wieslawa A Grajkowska; Marta Perek-Polnik; Alexandre Vasiljevic; Cecile Faure-Conter; Anne Jouvet; Caterina Giannini; Amulya A Nageswara Rao; Kay Ka Wai Li; Ho-Keung Ng; Charles G Eberhart; Ian F Pollack; Ronald L Hamilton; G Yancey Gillespie; James M Olson; Sarah Leary; William A Weiss; Boleslaw Lach; Lola B Chambless; Reid C Thompson; Michael K Cooper; Rajeev Vibhakar; Peter Hauser; Marie-Lise C van Veelen; Johan M Kros; Pim J French; Young Shin Ra; Toshihiro Kumabe; Enrique López-Aguilar; Karel Zitterbart; Jaroslav Sterba; Gaetano Finocchiaro; Maura Massimino; Erwin G Van Meir; Satoru Osuka; Tomoko Shofuda; Almos Klekner; Massimo Zollo; Jeffrey R Leonard; Joshua B Rubin; Nada Jabado; Steffen Albrecht; Jaume Mora; Timothy E Van Meter; Shin Jung; Andrew S Moore; Andrew R Hallahan; Jennifer A Chan; Daniela P C Tirapelli; Carlos G Carlotti; Maryam Fouladi; José Pimentel; Claudia C Faria; Ali G Saad; Luca Massimi; Linda M Liau; Helen Wheeler; Hideo Nakamura; Samer K Elbabaa; Mario Perezpeña-Diazconti; Fernando Chico Ponce de León; Shenandoah Robinson; Michal Zapotocky; Alvaro Lassaletta; Annie Huang; Cynthia E Hawkins; Uri Tabori; Eric Bouffet; Ute Bartels; Peter B Dirks; James T Rutka; Gary D Bader; Jüri Reimand; Anna Goldenberg; Vijay Ramaswamy; Michael D Taylor
Journal:  Cancer Cell       Date:  2017-06-12       Impact factor: 31.743

8.  Cell cycle control of Wnt/β-catenin signalling by conductin/axin2 through CDC20.

Authors:  Michel V Hadjihannas; Dominic B Bernkopf; Martina Brückner; Jürgen Behrens
Journal:  EMBO Rep       Date:  2012-04       Impact factor: 8.807

Review 9.  Medulloblastoma: developmental mechanisms out of control.

Authors:  Silvia Marino
Journal:  Trends Mol Med       Date:  2005-01       Impact factor: 11.951

Review 10.  In vitro models of medulloblastoma: Choosing the right tool for the job.

Authors:  Delyan P Ivanov; Beth Coyle; David A Walker; Anna M Grabowska
Journal:  J Biotechnol       Date:  2016-08-03       Impact factor: 3.307

View more
  3 in total

1.  Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma.

Authors:  Andrea Martins-da-Silva; Mirella Baroni; Karina Bezerra Salomão; Pablo Ferreira das Chagas; Ricardo Bonfim-Silva; Lenisa Geron; Gustavo Alencastro Veiga Cruzeiro; Wilson Araújo da Silva; Carolina Alves Pereira Corrêa; Carlos Gilberto Carlotti; Rosane Gomes de Paula Queiroz; Suely Kazue Nagahashi Marie; Silvia Regina Brandalise; José Andrés Yunes; Carlos Alberto Scrideli; Elvis Terci Valera; Luiz Gonzaga Tone
Journal:  Cell Mol Neurobiol       Date:  2022-04-02       Impact factor: 5.046

2.  Methylation Profiling of Medulloblastoma in a Clinical Setting Permits Sub-classification and Reveals New Outcome Predictions.

Authors:  Musa Alharbi; Nahla Mobark; Yara Bashawri; Leen Abu Safieh; Albandary Alowayn; Rasha Aljelaify; Mariam AlSaeed; Amal Almutairi; Fatimah Alqubaishi; Ebtehal AlSolme; Maqsood Ahmad; Ayman Al-Banyan; Fahad E Alotabi; Jonathan Serrano; Matija Snuderl; May Al-Rashed; Malak Abedalthagafi
Journal:  Front Neurol       Date:  2020-03-20       Impact factor: 4.003

Review 3.  Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment.

Authors:  Sutapa Ray; Nagendra K Chaturvedi; Kishor K Bhakat; Angie Rizzino; Sidharth Mahapatra
Journal:  Diagnostics (Basel)       Date:  2021-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.